心血管自主神经病变对1型糖尿病成人运动心肺、交感肾上腺及代谢反应的影响
该研究比较了伴或不伴心血管自主神经病变(CAN)的1型糖尿病成人对分级最大运动试验(GXT)的心肺、交感肾上腺及代谢反应。结果显示,伴CAN者峰值摄氧量降低,多项心肺、乳酸及运动表现指标减弱,峰值肾上腺素和去甲肾上腺素浓度及运动前后变化幅度均更低,而运动全程血糖两组相似且较静息无变化。结论提示CAN与运动不耐受相关,制定个体化运动计划时应筛查CAN。
要点
- 伴CAN的1型糖尿病成人峰值摄氧量(VO2peak)显著低于不伴CAN者(19.6±5.4 vs 27.5±7.8 ml kg-1 min-1)。
- 伴CAN者峰值肾上腺素和去甲肾上腺素浓度及从静息到峰值的变化幅度均显著低于不伴CAN者。
- 运动全程血糖两组相似且较静息无变化,提示CAN不影响运动中的血糖反应。
核心结论
- 在1型糖尿病成人中,CAN与运动不耐受相关,表现为心肺、交感肾上腺系统及代谢反应的多项受损。
- 研究数据支持在制定个体化体育训练计划时筛查CAN的存在。
研究设计与样本
- 研究比较了24例伴CAN的1型糖尿病成人(CAN组)与24例匹配的不伴CAN者(NO CAN组)在分级最大运动试验(GXT)中的反应。
- 运动中连续采集心肺变量(呼吸气体分析),并在运动期间每3分钟及峰值负荷时测定血浆肾上腺素、去甲肾上腺素、血糖和乳酸浓度。
- 统计分析采用独立t检验和双因素方差分析,显著性水平为p≤0.05。
主要发现
- CAN组峰值摄氧量(VO2peak)为19.6±5.4 ml kg-1 min-1,NO CAN组为27.5±7.8 ml kg-1 min-1。
- CAN组在GXT期间多项其他心肺、乳酸及运动表现变量较NO CAN组减弱。
- CAN组峰值肾上腺素浓度为0.17±0.12 ng/ml,NO CAN组为0.38±0.27 ng/ml(p=0.002)。
- CAN组峰值去甲肾上腺素浓度为1.86±1.04 ng/ml,NO CAN组为2.85±1.23 ng/ml(p=0.007)。
- CAN组肾上腺素从静息到峰值的变化幅度为Δ+0.13±0.12 ng/ml,NO CAN组为Δ+0.32±0.24 ng/ml(p=0.005);去甲肾上腺素变化幅度分别为Δ+1.33±0.89 ng/ml和Δ+2.33±1.30 ng/ml(p=0.005)。
临床怎么用
- 对1型糖尿病成人制定个体化运动训练计划前,应考虑筛查心血管自主神经病变(CAN)。
- 伴CAN者运动时心肺适能和交感肾上腺反应可能受损,需关注运动不耐受风险。
- 运动过程中血糖反应可能不因CAN状态而异,但仍需个体化监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: The aim of this work was to compare the cardiopulmonary, sympathoadrenal and metabolic responses to physical exercise in adults with type 1 diabetes with or without cardiovascular autonomic neuropathy (CAN). METHODS: Data collected during a graded maximal exercise test (GXT) from 24 participants with type 1 diabetes and CAN were compared against 24 matched control individuals without CAN (NO CAN). Throughout exercise, integrated cardiopulmonary variables were obtained continuously via spiroergometry. Plasma concentrations of adrenaline (epinephrine), noradrenaline (norepinephrine), glucose (PG) and lactate (PLa) were measured in 3 min intervals during exercise as well as at the peak workload. Data were assessed via independent t tests and two-factor ANOVAs with significance accepted at p≤0.05. RESULTS: Participants with CAN displayed a reduced V ˙ O 2 peak (CAN 19.6 ± 5.4 vs NO CAN 27.5 ± 7.8 ml kg-1 min-1) as well as attenuations in several other cardiopulmonary, lactate and exercise performance variables during GXT. Peak catecholamine concentrations were lower in CAN vs NO CAN (AD 0.17 ± 0.12 vs 0.38 ± 0.27 ng/ml, p=0.002; NAD 1.86 ± 1.04 vs 2.85 ± 1.23 ng/ml, p=0.007) as were the magnitudes of change in hormonal concentrations from rest to peak workloads (adrenaline Δ +0.13 ± 0.12 vs Δ +0.32 ± 0.24 ng/ml, p=0.005; noradrenaline Δ +1.33 ± 0.89 vs Δ +2.33 ± 1.30 ng/ml, p=0.005). PG concentrations throughout exercise were similar between groups and remained unchanged from rested values irrespective of CAN status. CONCLUSIONS/INTERPRETATION: In adults with type 1 diabetes, CAN was associated with exercise intolerance characterised by impairments in various cardiopulmonary, sympathoadrenal system and metabolic responses to GXT. These data support uncovering the presence of CAN when prescribing a personalised physical training plan.
引用
- McCarthy OM, Brødsgaard RB, Tawfik S, et al. Impact of cardiovascular autonomic neuropathy on cardiopulmonary, sympathoadrenal and metabolic responses to physical exercise in adults with type 1 diabetes. Diabetologia. 2025. PMID: 41364197. doi:10.1007/s00125-025-06619-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。